Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Guadalupe Cabral
HLA-DR in Cytotoxic T Lymphocytes Predicts Breast Cancer Patients' Response to Neoadjuvant Chemotherapy
Frontiers in Immunology
Allergy
Immunology
Related publications
P53 Codon 72 Polymorphism Predicts the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer
Journal of Medical – Clinical Research & Reviews
MRP1 but Not MDR1 Is Associated With Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
Disease Markers
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Genetics
Neoadjuvant Chemotherapy in Breast Cancer
Neoadjuvant Chemotherapy: Role in Breast Cancer
Neutrophil–lymphocyte Ratio Predicts Response to Chemotherapy in Triple-Negative Breast Cancer
Current Oncology
Oncology
Comedications Influence Immune Infiltration and Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer
OncoImmunology
Oncology
Allergy
Immunology
Local-Regional Control According to Surrogate Markers of Breast Cancer Subtypes and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast Conserving Therapy
Breast Cancer Research
Cancer Research
Oncology
Correlation of Post-Neoadjuvant Chemotherapy Response on MRI With Final Histology in Breast Cancer Patients
Breast Cancer Research
Cancer Research
Oncology